Restricted accessCase reportFirst published online 2009-1
Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India
Ciprofloxacin has become the antibiotic of choice for the treatment of typhoid fever with the emergence and worldwide spread of Salmonella enterica typhi strains resistant to chloramphenicol. However, the rampant use of ciprofloxacin gradually led to an increase in its minimum inhibitory concentration against S. enterica typhi. This threatened its therapeutic efficacy and resulted in the re-emergence of chloramphenicol-sensitive S. enterica typhi strains.
Get full access to this article
View all access options for this article.
References
1.
Clinical Laboratory Standards Institute.Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth International Supplement.Wayne, Pennsylvania, USA.National Committee for Clinical Laboratory Standards. 2006 (M100-S16)
2.
ManchandaV, BhallP, SethiM, SharmaVK.Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serotype Typhi and Paratyphi A.Ind J Med Microbiol2006; 24: 101–6.
3.
AcharyaG, ButlerT, HoM.Treatment of typhoid fever: randomized trial of a a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol.Am J Trop Med Hyg1995; 52: 162–5.
4.
RahmanM, AhmadA, ShomaS.Decline in epidemic of multidrug resistant Salmonella Typhi is not associated with increase of antibiotic-susceptible strain in Bangladesh.Epidemiol Infect2002; 129: 29–34.
KumarR, SazawalS, SinhaA, SoodS, BhanMK.Typhoid Fever: Contemporary Issues as Related to Disease in India.Round Table Conference Series on Water Borne Disease, Ranbaxy Science Foundation, New Delhi1997; 2: 31–6.
8.
CrumpJA, KretsingerK, GayK.Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States Food Net multi-center retrospective cohort study.Antimicrob Agents Chemother2008; 52: 1278–84.
9.
BhuttaZA, KhanIA, ShadmaniM.Failure of short-course ceftriaxone chemotherapy for Multidrug-resistant typhoid fever in children: a randomized controlled trial in Pakistan.Antimicrob Agents Chemother2004; 44; 450–2.
10.
JesudasonMV, MalathyB, JohnTJ.Trend of increasing minimum inhibitory concentration of ciprofloxacin to Salmonella Typhi.Ind J Med Res1996; 103: 247–9.
